• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Biotech

Biotech

Page 15 of 19

Dow Starts Week Off With Sharp Gains, Closing Over 250 Points Higher
Finance

Here’s Why Biotech Stocks Are Soaring

By Contributing Writer
March 1, 2016
NASDAQ Climbs Above 5000 Points For First Time In 15 Years
Finance

These Companies Just Busted the IPO Drought

By Staff Writer
February 3, 2016
Symbolic - biotechnology - genetic engineering
Tech

Guess What This Early Skype Investor Is Betting on Now

By Senior Editor
February 2, 2016
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership

Gilead CEO John Martin Is Stepping Down After 20 Years

By Senior Editor
January 29, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Biotech Stocks Crashed and Nobody Knows Why

By Industry Analyst
January 29, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
Health

Biosimilars Are Coming After Big Pharma’s Bottom Line

By News Correspondent
January 12, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
International

Shire-Baxalta $32 Billion Merger Talks Said to Advance

By News Correspondent
January 3, 2016
Biotech’s Insane Year
Health

Biotech’s Insane Year

By Research Team
December 31, 2015
Inside of a Gilead Sciences Lab
Finance

Isis Pharmaceuticals Changes Its Name After Terrorists Attack Stock Price

By Tech Reporter
December 18, 2015
Packs of Wrigley chewing gum are displayed in Westerville, O
Tech

Doublemint Gum Is an Awesome Biosensor

By Contributing Writer
December 3, 2015
MSMB Capital Management CIO Martin Shkreli
Finance

Turing CEO Invested in This Penny Stock Biotech to Keep It Alive

By Blockchain Reporter
November 19, 2015
CNBC Events - Clinton Global Initiative 2015
Tech

A Theranos Deal With Safeway Stores May be Falling Apart

By Senior Editor
November 11, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

Astrazeneca is Buying ZS Pharma for $2.7 billion

By Crypto Correspondent
November 6, 2015
MSMB Capital Management CIO Martin Shkreli
Health

This super-expensive drug is getting a $1 rival

By Contributing Writer
October 23, 2015
Big pharma won’t stay silent in drug pricing debate for long
Health

Big pharma won’t stay silent in drug pricing debate for long

By Senior Editor
October 22, 2015

Most Popular

  • AI
    Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
    By Investment Desk
  • Economy
    One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
    By Market Analyst
  • Economy
    Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
    By News Correspondent
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.